Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse.

Cell-free DNA (cfDNA) is increasingly studied for its diverse applications in non-invasive detection. Non-randomly cleaved by nucleases and released into the bloodstream, cfDNA exhibits a variety of intrinsic fragmentation patterns indicative of cell status. Particularly, these fragmentation pattern...

Full description

Saved in:
Bibliographic Details
Main Authors: Ruiqing Fu, He Amy Su, Yi Zhao, Yafei Tian, Hongyan Chen, Daru Lu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0327483
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849429773692960768
author Ruiqing Fu
He Amy Su
Yi Zhao
Yafei Tian
Hongyan Chen
Daru Lu
author_facet Ruiqing Fu
He Amy Su
Yi Zhao
Yafei Tian
Hongyan Chen
Daru Lu
author_sort Ruiqing Fu
collection DOAJ
description Cell-free DNA (cfDNA) is increasingly studied for its diverse applications in non-invasive detection. Non-randomly cleaved by nucleases and released into the bloodstream, cfDNA exhibits a variety of intrinsic fragmentation patterns indicative of cell status. Particularly, these fragmentation patterns have recently been demonstrated to be effective in predicting cancer and its tissue-of-origin, owing to increased variation of fragmentation features observed in tumor patients. However, there remains a lack of detailed exploration of altered cfDNA fragmentation profiles in tumors, which consist of a mixture of both non-tumor cfDNA and circulating tumor DNA (ctDNA). Hence, we leveraged the human tumor cell line-derived xenograft (CDX) mouse model, where different tumor cell lines were implanted into different anatomical sites, to isolate pure ctDNA and separately investigate the fragment properties of CDX-cfDNA and ctDNA. We found an enrichment of short cfDNA fragments in both CDX-cfDNA and ctDNA compared to normal plasma cfDNA, with more elevated short fragments in ctDNA. Moreover, the CDX-cfDNA fragmentation features distinguished between CDX models of different tumor cell lines, while the ctDNA fragmentation features conversely discriminate between CDX models of different anatomical sites. The results suggested that both non-tumor cfDNA and ctDNA contribute to the increased variation observed in tumors, and that cfDNA fragmentation may be highly variable and susceptible to regulations by both original cells and cells within the local niche.
format Article
id doaj-art-1925bd445dd74d3ab5fc7c927e953245
institution Kabale University
issn 1932-6203
language English
publishDate 2025-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-1925bd445dd74d3ab5fc7c927e9532452025-08-20T03:28:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032025-01-01207e032748310.1371/journal.pone.0327483Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse.Ruiqing FuHe Amy SuYi ZhaoYafei TianHongyan ChenDaru LuCell-free DNA (cfDNA) is increasingly studied for its diverse applications in non-invasive detection. Non-randomly cleaved by nucleases and released into the bloodstream, cfDNA exhibits a variety of intrinsic fragmentation patterns indicative of cell status. Particularly, these fragmentation patterns have recently been demonstrated to be effective in predicting cancer and its tissue-of-origin, owing to increased variation of fragmentation features observed in tumor patients. However, there remains a lack of detailed exploration of altered cfDNA fragmentation profiles in tumors, which consist of a mixture of both non-tumor cfDNA and circulating tumor DNA (ctDNA). Hence, we leveraged the human tumor cell line-derived xenograft (CDX) mouse model, where different tumor cell lines were implanted into different anatomical sites, to isolate pure ctDNA and separately investigate the fragment properties of CDX-cfDNA and ctDNA. We found an enrichment of short cfDNA fragments in both CDX-cfDNA and ctDNA compared to normal plasma cfDNA, with more elevated short fragments in ctDNA. Moreover, the CDX-cfDNA fragmentation features distinguished between CDX models of different tumor cell lines, while the ctDNA fragmentation features conversely discriminate between CDX models of different anatomical sites. The results suggested that both non-tumor cfDNA and ctDNA contribute to the increased variation observed in tumors, and that cfDNA fragmentation may be highly variable and susceptible to regulations by both original cells and cells within the local niche.https://doi.org/10.1371/journal.pone.0327483
spellingShingle Ruiqing Fu
He Amy Su
Yi Zhao
Yafei Tian
Hongyan Chen
Daru Lu
Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse.
PLoS ONE
title Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse.
title_full Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse.
title_fullStr Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse.
title_full_unstemmed Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse.
title_short Dissecting cell-free DNA fragmentation variation in tumors using cell line-derived xenograft mouse.
title_sort dissecting cell free dna fragmentation variation in tumors using cell line derived xenograft mouse
url https://doi.org/10.1371/journal.pone.0327483
work_keys_str_mv AT ruiqingfu dissectingcellfreednafragmentationvariationintumorsusingcelllinederivedxenograftmouse
AT heamysu dissectingcellfreednafragmentationvariationintumorsusingcelllinederivedxenograftmouse
AT yizhao dissectingcellfreednafragmentationvariationintumorsusingcelllinederivedxenograftmouse
AT yafeitian dissectingcellfreednafragmentationvariationintumorsusingcelllinederivedxenograftmouse
AT hongyanchen dissectingcellfreednafragmentationvariationintumorsusingcelllinederivedxenograftmouse
AT darulu dissectingcellfreednafragmentationvariationintumorsusingcelllinederivedxenograftmouse